Restless Legs Syndrome

Restless legs syndrome (RLS)—also referred to as Ekbom’s disease, Wittmaack-Ekbom syndrome, or simply RLS in clinical terminology—is primarily characterized by persistent sensations of discomfort, profound fatigue, and an irresistible urge to move the lower extremities. Patients commonly report paresthetic symptoms, including tingling, burning, or tension-like sensations that may mimic vascular swelling or tissue distension. Epidemiological evidence indicates that this sensorimotor neurological disorder affects nearly 10% of the general population, positioning it among the more prevalent yet often underdiagnosed conditions.

Notwithstanding the rapid advancements in medical science, the precise pathophysiological underpinnings of restless legs syndrome (RLS, also referred to as Ekbom disease or Wittmaack-Ekbom syndrome) remain incompletely elucidated by researchers. Nevertheless, a substantial body of clinical and epidemiological evidence points to significant correlations between the manifestation of RLS and specific comorbid conditions as well as environmental factors. One of the most pronounced associations exists with chronic renal failure—statistical data indicate that between 60% and 80% of patients diagnosed with nephropathy report characteristic motor disturbances in the lower extremities during the course of their illness. Another frequently observed phenomenon within this patient population is iron deficiency, which may disrupt dopamine synthesis—a neurotransmitter that plays a pivotal role in regulating involuntary movements. Furthermore, the impact of pharmacotherapy should not be overlooked, particularly the use of antidepressant medications from the selective serotonin reuptake inhibitor (SSRI) class and antipsychotic drugs, both of which have been implicated in either inducing or exacerbating RLS symptoms. An additional critical consideration is the dopaminergic deficit within the nervous system, which may arise from metabolic or neurodegenerative processes. Compelling evidence from familial case analyses further suggests a strong genetic predisposition, with approximately 50% of individuals diagnosed with RLS reporting similar symptoms among first-degree relatives. Initial manifestations of the disorder typically emerge after the age of 20, with a propensity for gradual intensification over subsequent years—a pattern that may imply a progressive nature of the underlying pathology.

Prior to examining the specific indicators of restless legs syndrome (RLS), also referred to as Wittmaack-Ekbom syndrome, it is essential to comprehend the diagnostic framework for this condition. The disorder is identified solely through a comprehensive patient history and the subjective symptoms reported by the individual. During a neurological consultation, the precise analysis of four fundamental criteria becomes paramount, as these enable the differentiation of RLS from other medical conditions. It is critical to ascertain whether the experienced discomfort is distinctly unpleasant and, in certain instances, painful, and whether its occurrence is confined exclusively to the lower limbs. Additionally, it is necessary to determine if the described symptoms manifest only during periods of rest and whether their severity diminishes or entirely subsides with physical activity. Equally important is the recognition of the time of day when symptoms reach their peak intensity—typically in the evening and nighttime hours for individuals with RLS. It must be emphasized that the symptomatology of restless legs syndrome often proves challenging to define unambiguously, both for healthcare professionals and patients alike. Those affected by this condition frequently characterize their sensations as involuntary, diffuse, and difficult-to-pinpoint discomforts, resembling tingling, numbness, muscle tightness, or even a sensation of swelling in the legs. Although descriptions vary widely, they share a unifying trait: the intensity of these sensations is sufficiently distressing to prevent the individual from focusing on any other task. The persistent and uncomfortable feelings in the lower extremities compel the patient to engage in movement, which serves as the sole effective means of alleviation. Patients commonly report performing repetitive, rhythmic flexion and extension movements of the legs to relieve excessive tension. These symptoms predominantly emerge at night, leading to frequent awakenings to "activate" the numb or tense limbs. The consequence of these compulsive nocturnal movements may include the development of chronic insomnia, impairments in concentration and memory, heightened irritability, and an overall decline in both mental well-being and physical condition.

Contemporary medicine has yet to develop definitive curative interventions for idiopathic restless legs syndrome (RLS), also referred to as Ekbom disease. Within clinical practice, healthcare providers frequently prescribe pharmacotherapeutic regimens involving skeletal muscle relaxants or vitamin-mineral supplementation to address potential micronutrient deficiencies. Furthermore, a cornerstone of symptom management involves comprehensive lifestyle modifications, particularly the exclusion of substances and behaviors known to exacerbate manifestations—including alcoholic beverages, caffeine-containing products, sedative-hypnotic or psychotropic medications, and tobacco products. Presently, the most empirically supported self-administered intervention for mitigating RLS symptoms remains physical activity. Patients consistently report that even brief exercise sessions—comprising basic lower-limb movements or stretching routines—yield substantial relief from distressing sensations. Additionally, some individuals find that engaging in cognitively demanding tasks provides temporary distraction from the unpleasant sensory experiences associated with the condition.